ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.52
-1.13%
US Tech 100
20,263.20
-1.69%
S&P 500
5,827.04
-1.54%
US Dollar vs CAD
1.4426
-0.66%
Bitcoin
94,330.79
-0.40%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. RenovoRx Inc (RNXT)

  7. RenovoRx Inc (RNXT) News

RNXT

RenovoRx (RNXT)

RenovoRx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RNXT
DateTimeSourceHeadlineSymbolCompany
01/08/20257:00AMBusiness WireRenovoRx Announces Acceptance of Abstract for Presentation at ASCO Gastrointestinal Cancers Symposium 2025NASDAQ:RNXTRenovoRx Inc
12/30/20247:00AMBusiness WireRenovoRx Continues to Grow Intellectual Property Portfolio for its Novel Drug-Delivery Therapy PlatformNASDAQ:RNXTRenovoRx Inc
12/11/20247:00AMGlobeNewswire Inc.RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic CancerNASDAQ:RNXTRenovoRx Inc
12/10/20247:00AMGlobeNewswire Inc.RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ETNASDAQ:RNXTRenovoRx Inc
12/05/20247:00AMGlobeNewswire Inc.RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery SystemNASDAQ:RNXTRenovoRx Inc
11/20/20247:45AMGlobeNewswire Inc.Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical TrialNASDAQ:RNXTRenovoRx Inc
11/14/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
11/14/20247:00AMGlobeNewswire Inc.RenovoRx Reports Third Quarter 2024 Financial Results and Operational HighlightsNASDAQ:RNXTRenovoRx Inc
11/13/20243:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
10/02/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
10/02/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
09/25/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
09/25/20247:30AMGlobeNewswire Inc.RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology PhysiciansNASDAQ:RNXTRenovoRx Inc
09/19/20247:30AMGlobeNewswire Inc.RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic CancerNASDAQ:RNXTRenovoRx Inc
08/27/20247:30AMGlobeNewswire Inc.RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New YorkNASDAQ:RNXTRenovoRx Inc
08/16/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
08/14/20247:30AMGlobeNewswire Inc.RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical TrialNASDAQ:RNXTRenovoRx Inc
08/13/20244:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
07/31/20247:30AMGlobeNewswire Inc.RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®NASDAQ:RNXTRenovoRx Inc
07/08/20247:30AMGlobeNewswire Inc.RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®NASDAQ:RNXTRenovoRx Inc
06/26/20247:30AMGlobeNewswire Inc.University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical TrialNASDAQ:RNXTRenovoRx Inc
06/10/20247:30AMGlobeNewswire Inc.RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and PartnershipsNASDAQ:RNXTRenovoRx Inc
06/07/20243:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
05/30/20247:30AMBusiness WireRenovoRx CEO Issues Update Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
05/21/20248:00AMBusiness WirePublication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliveryNASDAQ:RNXTRenovoRx Inc
05/14/20248:00AMBusiness WireRenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024NASDAQ:RNXTRenovoRx Inc
05/12/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
05/12/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
05/10/20244:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
05/10/20243:50PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNXTRenovoRx Inc
 Showing the most relevant articles for your search:NASDAQ:RNXT

Your Recent History

AMEX
SPY
SPDR S&P 500
USOTC
NBRI
North Bay Resources (PK)
USOTC
NLST
Netlist (QB)
NASDAQ
MULN
Mullen Automotive
NASDAQ
ILLR
Triller
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
RNVA
Rennova Health (CE)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
GTCH
GBT Technologies (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
HIRU
Hiru (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
HMBL
HUMBL (PK)
NASDAQ
TNXP
Tonix Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads